[go: up one dir, main page]

AU5448300A - Methods of promoting or enhancing interleukin-12 production through administration of thalidomide - Google Patents

Methods of promoting or enhancing interleukin-12 production through administration of thalidomide

Info

Publication number
AU5448300A
AU5448300A AU54483/00A AU5448300A AU5448300A AU 5448300 A AU5448300 A AU 5448300A AU 54483/00 A AU54483/00 A AU 54483/00A AU 5448300 A AU5448300 A AU 5448300A AU 5448300 A AU5448300 A AU 5448300A
Authority
AU
Australia
Prior art keywords
thalidomide
promoting
administration
production
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54483/00A
Inventor
Patrick A. J. Haslett
Gilla Kaplan
Stephen J. Oliver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of AU5448300A publication Critical patent/AU5448300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54483/00A 1999-05-27 2000-05-26 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide Abandoned AU5448300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32145699A 1999-05-27 1999-05-27
US09321456 1999-05-27
PCT/US2000/014784 WO2000072836A2 (en) 1999-05-27 2000-05-26 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide

Publications (1)

Publication Number Publication Date
AU5448300A true AU5448300A (en) 2000-12-18

Family

ID=23250688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54483/00A Abandoned AU5448300A (en) 1999-05-27 2000-05-26 Methods of promoting or enhancing interleukin-12 production through administration of thalidomide

Country Status (2)

Country Link
AU (1) AU5448300A (en)
WO (1) WO2000072836A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163595A1 (en) 2001-12-21 2003-08-07 Gruenenthal Gmbh 3-position heterocyclic substituted piperidine-2,6-diones
EP3054946A2 (en) * 2013-10-09 2016-08-17 University Of Miami Perforin-2 activators and inhibitors as drug targets for infectious disease and gut inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69738935D1 (en) * 1996-11-05 2008-10-02 Childrens Medical Center Compositions containing thalidomide and dexamethasone for the treatment of cancer
EP0893122A1 (en) * 1997-07-25 1999-01-27 Ferdinando Ippolito Topical composition comprising thalidomide and their use in cutaneous pathologies
DE19743968C2 (en) * 1997-10-06 2002-07-11 Gruenenthal Gmbh Intravenous application form of thalidomide for the therapy of immunological diseases

Also Published As

Publication number Publication date
WO2000072836A8 (en) 2001-09-13
WO2000072836A2 (en) 2000-12-07
WO2000072836A3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU1177601A (en) Block toy
IL149907A0 (en) Nutritional composition, methods of producing said composition and methods of using said composition
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU1101699A (en) Therapeutic pillow
PL351686A1 (en) Novel pharmaceutical
AU715620C (en) Therapeutic methods and uses
AU1409100A (en) Drugs
EG23937A (en) Novel pharmaceutical
AU7332800A (en) Card construction, methods of making and using
AU3467099A (en) Methods for production of therapeutic cytokines
AU7445100A (en) Sebum production inhibitors
PL354994A1 (en) Bio-supportive matrices, methods of making and using the same
HUP0201667A2 (en) Oral form of administration
GB9909041D0 (en) Novel pharmaceutical
EG23946A (en) Novel pharmaceutical
HUP0401622A3 (en) Gelling sugar and method for producing the same
AU2612100A (en) Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
AU5448300A (en) Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
HUP0203443A3 (en) Novel contraceptive medicament and method for producing the same
AU1601801A (en) Methods of preparing crna
AU6194899A (en) Pharmaceutical preparation containing taxane and method for producing the same
AU2279800A (en) Pharmaceutical preparation
AUPP574298A0 (en) Pharmaceutical preparation
AUPQ037399A0 (en) Novel compounds and therapeutic methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase